Literature DB >> 16586024

Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters.

Mariana Buss Cezar Fontana1, Maria do Carmo Freire de Bastos, Adriano Brandelli.   

Abstract

Pep5 and epidermin bacteriocins were tested on clinical strains of Staphylococcus epidermidis and S. aureus isolated from catheter-related infections. These bacteriocins were inhibitory to several isolates at a concentration of 640 activity units mL(-1). The ability of bacteriocins in inhibiting adhesion of S. epidermidis to silicone catheters was evaluated. When Pep5 and epidermin were added to in vitro catheter colonization experiments, there was a significant decrease in the cell number of S. epidermidis adhered to silicone catheters. Bacteriocins used to decrease bacterial attachment to medical devices may represent a novel strategy to control catheter-related infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586024     DOI: 10.1007/s00284-005-0152-5

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  19 in total

Review 1.  Bacteriocins: evolution, ecology, and application.

Authors:  Margaret A Riley; John E Wertz
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

2.  Protein antimicrobial barriers to bacterial adhesion.

Authors:  C K Bower; M A Daeschel; J McGuire
Journal:  J Dairy Sci       Date:  1998-10       Impact factor: 4.034

Review 3.  Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria.

Authors:  H G Sahl; G Bierbaum
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

4.  Enzymatic removal and disinfection of bacterial biofilms.

Authors:  C Johansen; P Falholt; L Gram
Journal:  Appl Environ Microbiol       Date:  1997-09       Impact factor: 4.792

5.  Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis.

Authors:  H G Sahl; H Brandis
Journal:  J Gen Microbiol       Date:  1981-12

6.  Production of bacteriocins by coagulase-negative staphylococci involved in bovine mastitis.

Authors:  Janaína dos Santos Nascimento; Patricia Carlin Fagundes; Maria Aparecida Vasconcelos de Paiva Brito; Kátia Regina Netto dos Santos; Maria do Carmo de Freire Bastos
Journal:  Vet Microbiol       Date:  2005-03-20       Impact factor: 3.293

Review 7.  Staphylococcus epidermidis infections.

Authors:  Cuong Vuong; Michael Otto
Journal:  Microbes Infect       Date:  2002-04       Impact factor: 2.700

8.  Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.

Authors:  D G Maki; S M Stolz; S Wheeler; L A Mermel
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

9.  Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.

Authors:  D Pittet; D Tarara; R P Wenzel
Journal:  JAMA       Date:  1994-05-25       Impact factor: 56.272

10.  Antibiotics and prevention of microbial colonization of catheters.

Authors:  I Raad; R Darouiche; R Hachem; M Sacilowski; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

View more
  12 in total

Review 1.  Bacteriocins - a viable alternative to antibiotics?

Authors:  Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Nat Rev Microbiol       Date:  2012-12-24       Impact factor: 60.633

Review 2.  Shaping of cutaneous function by encounters with commensals.

Authors:  Emma Barnard; Huiying Li
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

Review 3.  Features and applications of Ent35-MccV hybrid bacteriocin: current state and perspectives.

Authors:  S A Navarro; L Lanza; L Acuña; A Bellomio; Miriam C Chalón
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-16       Impact factor: 4.813

4.  Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci.

Authors:  Stephanie Sandiford; Mathew Upton
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 5.  Efficiency of Antimicrobial Peptides Against Multidrug-Resistant Staphylococcal Pathogens.

Authors:  Mi Nguyen-Tra Le; Miki Kawada-Matsuo; Hitoshi Komatsuzawa
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

6.  In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria.

Authors:  Alan J Marsh; Orla O'Sullivan; R Paul Ross; Paul D Cotter; Colin Hill
Journal:  BMC Genomics       Date:  2010-11-30       Impact factor: 3.969

7.  The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.

Authors:  Clare Piper; Pat G Casey; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Int J Microbiol       Date:  2012-01-12

8.  Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis.

Authors:  Teruaki Nakatsuji; Tiffany H Chen; Saisindhu Narala; Kimberly A Chun; Aimee M Two; Tong Yun; Faiza Shafiq; Paul F Kotol; Amina Bouslimani; Alexey V Melnik; Haythem Latif; Ji-Nu Kim; Alexandre Lockhart; Keli Artis; Gloria David; Patricia Taylor; Joanne Streib; Pieter C Dorrestein; Alex Grier; Steven R Gill; Karsten Zengler; Tissa R Hata; Donald Y M Leung; Richard L Gallo
Journal:  Sci Transl Med       Date:  2017-02-22       Impact factor: 17.956

9.  A plant endophyte Staphylococcus hominis strain MBL_AB63 produces a novel lantibiotic, homicorcin and a position one variant.

Authors:  M Aftab Uddin; Shammi Akter; Mahbuba Ferdous; Badrul Haidar; Al Amin; A H M Shofiul Islam Molla; Haseena Khan; Mohammad Riazul Islam
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

Review 10.  Bioengineering Lantibiotics for Therapeutic Success.

Authors:  Des Field; Paul D Cotter; Colin Hill; R P Ross
Journal:  Front Microbiol       Date:  2015-11-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.